Skip to main content

Table 2 Clinical outcomes

From: Association of haemoglobin glycation index with outcomes in patients with acute coronary syndrome: results from an observational cohort study in China

Variable

Total population

Quintile 1

Quintile 2

Quintile 3

Quintile 4

Quintile 5

p value

n = 11004

n = 2199

n = 2202

n = 2201

n = 2201

n = 2201

All-cause death

784 (7.1%)

183 (8.3%)

112 (5.1%)

132 (6.0%)

162 (7.4%)

195 (8.9%)

 < 0.001

CV death

420 (3.8%)

99 (4.5%)

58 (2.6%)

65 (3.0%)

84 (3.8%)

114 (5.2%)

 < 0.001

Non-fatal MI

457 (4.2%)

91 (4.1%)

87 (4.0%)

81 (3.7%)

87 (4.0%)

111 (5.0%)

0.194

Cardiac rehospitalization

2638 (24.0%)

546 (24.8%)

498 (22.6%)

514 (23.4%)

520 (23.6%)

560 (25.4%)

0.176

Revascularization

739 (6.7%)

137 (6.2%)

142 (6.4%)

138 (6.3%)

148 (6.7%)

174 (7.9%)

0.150

Non-fatal stroke

164 (1.5%)

34 (1.5%)

28 (1.3%)

22 (1.0%)

38 (1.7%)

42 (1.9%)

0.098

Composite MACCEs

3298 (30.0%)

687 (31.2%)

606 (27.5%)

619 (28.1%)

662 (30.1%)

724 (32.9%)

 < 0.001

  1. CV cardiovascular, MI myocardial infarction, MACCEs Major Adverse Cardiac and Cerebrovascular events